Autopsy report · NCT04056429

Multiregion BHA in Open Tibia Fractures

“study never started and is delayed until further notice”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Carmell Therapeutics Corporation

Sponsor type

Industry

Conditions

Tibial Fractures

Interventions

BHA

Participants

0

Trials that died the same way

• Clearblue Advanced Fertility Monitor Consumer Three Cycle at Home Study
  “Study not started, no longer required” (80% match in meaning)
• Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer
  “Study never moved forward due to no accrual” (76% match in meaning)
• Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma
  “Study stopped due to slow enrollment” (74% match in meaning)
• Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
  “Investigator decided not to move forward with study prior to study start date” (73% match in meaning)
• Cancer and Mild Cognitive Impairment a Patient-Caregiver Behavioral Intervention
  “Study halted prematurely, prior to enrollment of first participant” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.